Literature DB >> 26689853

Rapid Resolution of Donor-Derived Glomerular Fibrin Thrombi After Deceased Donor Kidney Transplantation.

R K Batra1, R L Heilman2, M L Smith3, L F Thomas2, H A Khamash2, N N Katariya1, W R Hewitt1, A L Singer1, A K Mathur1, J Huskey2, H A Chakkera2, A Moss1, K S Reddy1.   

Abstract

The aim of this study was to determine the clinical and histologic outcomes related to transplanting kidneys from deceased donors with glomerular fibrin thrombi (GFT). We included all cases transplanted between October 2003 and October 2014 that had either a preimplantation biopsy or an immediate postreperfusion biopsy showing GFT. The study cohort included 61 recipients (9.9%) with GFT and 557 in the control group without GFT. Delayed graft function occurred in 49% of the GFT group and 39% in the control group (p = 0.14). Serum creatinine at 1, 4, and 12 months and estimated GFR at 12 months were similar in the two groups. Estimated 1-year graft survival was 93.2% in the GFT group and 95.1% in the control group (p = 0.22 by log-rank). Fifty-two of the 61 patients in the GFT group (85%) had a 1-month protocol biopsy, and only two biopsies (4%) showed residual focal glomerular thrombi. At the 1-year protocol biopsy, the prevalence of moderate to severe interstitial fibrosis and tubular atrophy was 24% in the GFT group and 30% in the control group (p = 0.42). We concluded that GFT resolves rapidly after transplantation and that transplanting selected kidneys from deceased donors with GFT is a safe practice. © Copyright 2015 The American Society of Transplantation and the American Society of Transplant Surgeons.

Entities:  

Keywords:  biopsy; clinical research/practice; donors and donation: deceased; kidney transplantation / nephrology

Mesh:

Substances:

Year:  2015        PMID: 26689853     DOI: 10.1111/ajt.13561

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  4 in total

1.  Machine Retrograde Perfusion of Deceased Donor Kidneys: A Prospective Study.

Authors:  Jun Zeng; ZiHao Jia; Tao Lin; TuRun Song
Journal:  Front Med (Lausanne)       Date:  2021-12-17

2.  Aggravation of fibrin deposition and microthrombus formation within the graft during kidney transplantation.

Authors:  Tamar A J van den Berg; Marius C van den Heuvel; Janneke Wiersema-Buist; Jelle Adelmeijer; Gertrude J Nieuwenhuijs-Moeke; Ton Lisman; Stephan J L Bakker; Harry van Goor; Robert A Pol
Journal:  Sci Rep       Date:  2021-09-23       Impact factor: 4.379

3.  Novel Ex-Vivo Thrombolytic Reconditioning of Kidneys Retrieved 4 to 5 Hours After Circulatory Death.

Authors:  Michael Olausson; Deepti Antony; Galina Travnikova; Martin Johansson; Nikhil B Nayakawde; Debashish Banerjee; John Mackay Søfteland; Goditha U Premaratne
Journal:  Transplantation       Date:  2022-07-22       Impact factor: 5.385

4.  The use of thromboelastography to assess post-operative changes in coagulation and predict graft function in renal transplantation.

Authors:  Carson B Walker; Hunter B Moore; Trevor L Nydam; Alexander C Schulick; Hillary Yaffe; James J Pomposelli; Michael Wachs; Thomas Bak; Kendra Conzen; Megan Adams; Thomas Pshak; Rashikh Choudhury; Michael P Chapman; Elizabeth A Pomfret; Peter Kennealey
Journal:  Am J Surg       Date:  2020-08-27       Impact factor: 2.565

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.